Critical Care Clinical Trial
— CHECKLIST-ICUOfficial title:
Checklist During Multidisciplinary Daily Visits and Clinician Prompting for Reduction of Mortality in Intensive Care Units: A Cluster Randomized Trial
Verified date | November 2014 |
Source | Hospital do Coracao |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: National Health Surveillance Agency |
Study type | Interventional |
CHECKLIST-ICU will be a cluster randomized trial to ascertain whether the use of an
intervention including 1) checklists with assessment of daily goals during the
multidisciplinary visit, and 2) clinician prompting can reduce in-hospital mortality of
patients admitted to intensive care units (ICUs).
The investigators also aim to describe participant ICUs in terms of the standards for
intensive care units proposed by the Brazilian National Health Agency (ANVISA).
Status | Completed |
Enrollment | 13637 |
Est. completion date | November 2014 |
Est. primary completion date | November 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria for clusters: - Intensive care units, except dedicated coronary care units/cardiac intensive care units and step-down units; - Must have multidisciplinary daily rounds or coordinators agree to implement daily rounds, including at least one physician and one nurse, conducted at least on week days. Exclusion criteria for clusters: • We will exclude ICUs that systematically apply checklists in the multiprofessional daily visit. We define systematically applied checklist when all the following criteria are met: - Content: structured evaluation following a digital or printed document of multiple items focused on prevention of common ICU complications (eg. ventilator-associated pneumonia, stress ulcer, venous thromboembolism and/or catheter-associated bloodstream infection) and/or explicit assessment of daily goals; - Time frame: daily application of checklist for at least 30 days - Periodicity: at least 3 days per week - How is applied: verbal, observational (1 professional check all items), with or without written register Patient inclusion criteria: • Adult patients (=18 years-old) with anticipated ICU length of stay > 24 hours. Patient exclusion criteria; - High probability of death within 24 hours or patients admitted in ICU for palliative care only; - Suspected or confirmed brain death. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
Brazil | Alexandre Biasi Cavalcanti | São Paulo | SP |
Lead Sponsor | Collaborator |
---|---|
Hospital do Coracao | D'Or Institute for Research and Education, Sociedade Hospital Samaritano |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | In-hospital mortality truncated at 60 days | Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive. | Hospital discharge; average of 20 days; follow-up limited to 60 days | No |
Secondary | Head of the bed elevated at 30° | Every 3 three days, from ICU day 2 to 17 | No | |
Secondary | Adequate prophylaxis for venous thromboembolism | Every 3 three days, from ICU day 2 to 17 | No | |
Secondary | Patient-days under light sedation or alert and calm (RASS - 3 to 0) | Every 3 three days, from ICU day 2 to 17 | No | |
Secondary | Rate of central-line catheter use | Daily from ICU day 2 to 17 | No | |
Secondary | Indwelling urinary catheter use rate | Daily from ICU day 2 to 17 | No | |
Secondary | Rate of patients receiving enteral or parenteral feeding | Every 3 three days, from ICU day 2 to 17 | No | |
Secondary | Tidal volume <=8mL/kg of predicted body weight in patients on mechanical | Every 3 three days, from ICU day 2 to 17 | No | |
Secondary | ICU mortality | Follow-up will be limited to 60 days after ICU admission. Patients who are still in the ICU after 60 days of ICU admission will be considered as discharged alive. | ICU discharge; follow-up limited to 60 days | No |
Secondary | Central line-associated bloodstream infection (CLABSI) rate | Following the Centers for Disease Control/National Healthcare Safety Network (CDC/NHSN) Surveillance Definition of Healthcare-Associated Infection 2008 | Daily from ICU day 2 to 17 | No |
Secondary | Urinary tract infection associated with catheter rate | Daily from ICU day 2 to 17 | No | |
Secondary | Ventilator-associated pneumonia (VAP) | Daily from ICU day 2 to 17 | No | |
Secondary | Length of ICU stay | Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive. | Hospital discharge; follow-up limited to 60 days | No |
Secondary | Length of hospital stay | Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive. | Hospital discharge; average of 20 days; follow-up limited to 60 days | No |
Secondary | Mechanical ventilation-free days at 28 days | Survival time free of invasive mechanical ventilation from ICU admission to day 28. Patients who were discharged from hospital alive before 28 days are considered to be alive and free of mechanical ventilation until the 28th day. |
Day 28 after ICU admission | No |
Secondary | Safety Attitudes Questionnaire Score | Survey | In phase 1, between sept/2013 and january/2014 each ICU staff answered the questionnaire once. In phase 2, between july/2014 and december/2014 the questionnaire was applied again (once for each ICU staff). | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05114551 -
ICU Predictive Score of WEaning Success in Patients At Risk of Extubation Failure
|
||
Completed |
NCT05547646 -
The Prevalence of Healthcare-associated Infection in Medical Intensive Care Units in Tunisia
|
||
Recruiting |
NCT03697785 -
Weaning Algorithm for Mechanical VEntilation
|
N/A | |
Completed |
NCT02922101 -
Evaluation of the Effectiveness of an Audit and Feedback Intervention With Quality Improvement Toolbox in Intensive Care
|
N/A | |
Completed |
NCT02902783 -
DONATE-Pilot Study on ICU Management of Deceased Organ Donors
|
||
Completed |
NCT01885442 -
TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients
|
N/A | |
Completed |
NCT01857986 -
Evaluating Air Leak Detection in Intubated Patients
|
N/A | |
Recruiting |
NCT05518955 -
VR Integrated Into Multicomponent Interventions for Improving Sleep in ICU
|
N/A | |
Recruiting |
NCT03810768 -
Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
|
||
Completed |
NCT03295630 -
Validity of an Actigraph Accelerometer Following Critical Illness
|
N/A | |
Completed |
NCT05556811 -
HEaling LIght Algorithms for the ICU Patient
|
N/A | |
Recruiting |
NCT05702411 -
Air Stacking Technique For Pulmonary Reexpansion
|
N/A | |
Completed |
NCT02741453 -
Bilateral Internal Jugular Veins Ultrasound Scanning Prior to CVC Placement
|
N/A | |
Recruiting |
NCT04979897 -
Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic
|
||
Completed |
NCT05281224 -
Ventilator Tube Holder for Patients With a Tracheostomy
|
||
Withdrawn |
NCT02970903 -
VitalPAD: an Intelligent Monitoring and Communication Device to Optimize Safety in the PICU
|
N/A | |
Recruiting |
NCT02587273 -
The Pharmacokinetics of Fentanyl in Intensive Care Patients
|
Phase 4 | |
Completed |
NCT02661607 -
Point of Care Echocardiography Versus Chest Radiography for the Assessment of Central Venous Catheter Placement
|
N/A | |
Completed |
NCT01479153 -
Venous Site for Central Catheterization
|
N/A | |
Recruiting |
NCT06110390 -
High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients
|
N/A |